myHIVteam

Yes, Sunlenca (lenacapavir) has been approved by the FDA as a twice-yearly injectable treatment option for HIV. The FDA granted this approval in December 2022. Before starting the injectable form, you'll need to take an oral version of Sunlenca for up to one week to ensure you can tolerate the medication. After that initial Show Full Answer

Yes, Sunlenca (lenacapavir) has been approved by the FDA as a twice-yearly injectable treatment option for HIV. The FDA granted this approval in December 2022. Before starting the injectable form, you'll need to take an oral version of Sunlenca for up to one week to ensure you can tolerate the medication. After that initial period, you'll only need two injections per year. The medication works by disrupting the HIV capsid (the protein shell of the virus), which prevents the virus from infecting cells and forming new viruses.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Injectables for HIV Treatment and Prevention: How They Work

Injectables for HIV Treatment and Prevention: How They Work